ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hoya Corp (PK)

Hoya Corp (PK) (HOCPY)

137.80
0.24
(0.17%)
Closed 23 January 8:00AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
137.80
Bid
135.03
Offer
140.77
Volume
26,291
137.00 Day's Range 141.94
108.12 52 Week Range 148.27
Market Cap
Previous Close
137.56
Open
141.94
Last Trade
20
@
137.8
Last Trade Time
Financial Volume
US$ 3,635,706
VWAP
138.2871
Average Volume (3m)
19,822
Shares Outstanding
350,958,720
Dividend Yield
0.52%
PE Ratio
0.26
Earnings Per Share (EPS)
520.19
Revenue
792.22B
Net Profit
182.57B

About Hoya Corp (PK)

Sector
Ophthalmic Goods
Industry
Ophthalmic Goods
Website
Headquarters
Shinjuku, Tokyo, Jpn
Founded
1984
Hoya Corp (PK) is listed in the Ophthalmic Goods sector of the OTCMarkets with ticker HOCPY. The last closing price for Hoya (PK) was US$137.56. Over the last year, Hoya (PK) shares have traded in a share price range of US$ 108.12 to US$ 148.27.

Hoya (PK) currently has 350,958,720 shares in issue. The market capitalisation of Hoya (PK) is US$48.28 billion. Hoya (PK) has a price to earnings ratio (PE ratio) of 0.26.

HOCPY Latest News

Toshiba Signs $17.7 Billion Deal With Bain-Apple Group to Sell Chip Unit

By Takashi Mochizuki and Kosaku Narioka TOKYO-- Toshiba Corp. said it reached a legally-binding agreement with a group led by U.S. private-equity firm Bain Capital LLC to sell its memory chip unit...

SK Hynix To Invest In Toshiba Chip Deal -- WSJ

By Kwanwoo Jun This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (September 28, 2017...

FDA Warns Three Scope Makers

The Food and Drug Administration sent warning letters to the three makers of a specialized medical device that has been linked to outbreaks of so-called superbug infections at U.S. hospitals. The...

Hoya Vision Care Expands its Direct Presence in Brazil

Hoya Vision Care Expands its Direct Presence in Brazil PR Newswire TOKYO, April 3, 2012 TOKYO, April 3, 2012 /PRNewswire/ --  Hoya Corporation's Vision Care Division, a key player in the...

CORRECT: Olympus' Medical Business Could Make It Attractive Takeover Target

With Olympus Corp. (7733.TO) embroiled in scandal and facing the biggest challenge in its 92-year history that has wiped out about two-thirds of its market value since mid-October, its position as...

Olympus' Medical Business Could Make It Attractive Takeover Target

With Olympus Corp. (7733.TO) embroiled in scandal and facing the biggest challenge in its 92-year history that has wiped out more than a third of its market value since mid-October, its position...

Cynosure Acquires Aesthetic Laser Business of HOYA ConBio

Cynosure Acquires Aesthetic Laser Business of HOYA ConBio Transaction Further Strengthens Cynosure's Product Platform with Addition of Proprietary Q-Switched Nano-Second Laser Technology;...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
18.556.61508704062129.25141.94127.3840536131.96431971DR
411.7659.33470861269126.035141.94119.125620128.59885653DR
123.492.59846623483134.31145.1119.119822130.06971559DR
2616.13813.2646183689121.662148.27114.6417970131.16543742DR
5212.279.77455588306125.53148.27108.1222666125.60365585DR
15610.52358.26821919207127.2765148.2782.1535951109.69176979DR
26036.8136.4491533815100.99179.9470.3632063112.29240732DR

HOCPY - Frequently Asked Questions (FAQ)

What is the current Hoya (PK) share price?
The current share price of Hoya (PK) is US$ 137.80
How many Hoya (PK) shares are in issue?
Hoya (PK) has 350,958,720 shares in issue
What is the market cap of Hoya (PK)?
The market capitalisation of Hoya (PK) is USD 48.28B
What is the 1 year trading range for Hoya (PK) share price?
Hoya (PK) has traded in the range of US$ 108.12 to US$ 148.27 during the past year
What is the PE ratio of Hoya (PK)?
The price to earnings ratio of Hoya (PK) is 0.26
What is the cash to sales ratio of Hoya (PK)?
The cash to sales ratio of Hoya (PK) is 0.06
What is the reporting currency for Hoya (PK)?
Hoya (PK) reports financial results in JPY
What is the latest annual turnover for Hoya (PK)?
The latest annual turnover of Hoya (PK) is JPY 792.22B
What is the latest annual profit for Hoya (PK)?
The latest annual profit of Hoya (PK) is JPY 182.57B
What is the registered address of Hoya (PK)?
The registered address for Hoya (PK) is 6-10-1 NISHI, SHINJUKU-KU, SHINJUKU, TOKYO, 160-8347
What is the Hoya (PK) website address?
The website address for Hoya (PK) is www.hoya.co.jp
Which industry sector does Hoya (PK) operate in?
Hoya (PK) operates in the OPHTHALMIC GOODS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RTNBroot9B Holdings Inc (CE)
US$ 0.003003
(300,200.00%)
333
CTRYFCountry Garden Holdings Company Limited (CE)
US$ 0.075
(37,400.00%)
1.69k
CNQQFClean TeQ Water Ltd (PK)
US$ 0.18
(25,614.29%)
425
QBIOQ BioMed Inc (CE)
US$ 0.0002
(19,900.00%)
692
MGTIMGT Capital Investments Inc (CE)
US$ 0.0002
(19,900.00%)
15.63k
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0.000001
(-99.99%)
150
CONNQConns Inc (CE)
US$ 0.000001
(-99.98%)
250
SPECSpectaire Holdings Inc (CE)
US$ 0.000001
(-99.90%)
6.02k
EGOCEnergy One Corporation (CE)
US$ 0.000001
(-99.90%)
21.8k
GRTSQGritstone bio Inc (CE)
US$ 0.000001
(-99.90%)
223.35k
PDGOParadigm Oil and Gas Inc (PK)
US$ 0.0001
(-50.00%)
574.25M
RDARRaadr Inc (PK)
US$ 0.001
(-9.09%)
280.1M
COSGCosmos Group Holdings Inc (PK)
US$ 0.0002
(19,900.00%)
267.1M
HMBLHUMBL Inc (PK)
US$ 0.0008
(-11.11%)
251.13M
ASIIAccredited Solutions Inc (PK)
US$ 0.0005
(0.00%)
187.29M

Discussion

View Full Feed
vinmantoo vinmantoo 3 minutes ago
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 3 minutes ago
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 4 minutes ago
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 4 minutes ago
Whats 305
RNVA
theorysuit theorysuit 6 minutes ago
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 6 minutes ago
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 7 minutes ago
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 7 minutes ago
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 7 minutes ago
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 8 minutes ago
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 9 minutes ago
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 9 minutes ago
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 10 minutes ago
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX
Carjockey2 Carjockey2 10 minutes ago
You don't have to apologize to anybody certainly not me!!!

Family always is first.

Thank him for his Service is the only thing I would ask you to do from me.

$HMBL
HMBL
IAMNOTWALTAH IAMNOTWALTAH 10 minutes ago
I-Glow and Threefight are just two sides of the same coin, it’s just two people bashing and pumping without any actual concrete information and being vague when you ask them for actual proof by saying they heard stuff through the “grapevine” or copy and pasting the same paragraph they have been post
AVVH
janice shell janice shell 12 minutes ago
Default occurs when a party does nothing. That is what Megan will do. The SEC will request a default judgment, and it will be granted by the judge.

Megan won't pay up, and that will be the end.
boi568 boi568 12 minutes ago
First, this is technically only a guideline addressing FDA staff involved in the approval process. However, the effect of the guidance unavoidably impacts the results for companies submitting NDAs in early AD. That's why all the more formal rulemaking procedural elements are being applied; it's bei
AVXL
jobynimble jobynimble 13 minutes ago
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 22, 2025 09:00 ET

Source: KRTL Holding Group

Lakewood, CO, Jan. 22, 2025 (GLOBE NEWSWIRE) --
KRTL
biotechinvestor1 biotechinvestor1 14 minutes ago
Inconsequential. The UK decision has to do with Herceptin SC and Mabthera SC. Back then Roche did not file RHUPH20 as an active ingredient early in the process. So the court is saying that they should have done so from the beginning of their filing. Since then everyone has learned their lessons. 
HALO
JimmyTwoTimes JimmyTwoTimes 15 minutes ago
https://media4.giphy.com/media/kIVVupOM0VoW3bNuU7/giphy.gif?cid=6c09b952a8wkvsa7qrmsfrgtjsk2td2p9pidwjk21v4yg2om&ep=v1_internal_gif_by_id&rid=giphy.gif&ct=g
OWPC

Your Recent History

Delayed Upgrade Clock